The Trump administration on Monday proposed a rule requiring food and supplement makers to notify the FDA when they determine one of their own ingredients is safe for consumption. The proposal aims to close a longstanding loophole that allows companies to introduce new chemical ingredients without informing the FDA.
Health Secretary Robert F. Kennedy Jr. has pushed the change as a signature piece of his food policy agenda since taking office. The designation at the center of the fight, generally recognized as safe, currently lets companies self-certify certain food chemicals without strict government oversight.
A 1958 exemption still governs synthetic chemicals today
Congress carved out the GRAS exemption in 1958 when it defined food additive under the Federal Food, Drug, and Cosmetic Act. Lawmakers excluded substances already accepted as safe by qualified experts through long use or established science.
What began as a carve-out for everyday ingredients like vinegar or salt has since become the primary gateway for new synthetic additives entering American food. A 2013 Pew Research Center analysis found manufacturers used the exception to reach markets without agency review. Estimated companies had cleared roughly 1,000 chemicals as generally recognized as safe without ever notifying regulators.
No one currently has to tell the FDA anything
Under existing rules, a company can hire its own consultants to evaluate an ingredient, conclude it is safe, and start selling products containing it without the FDA ever reviewing the underlying data.
Reporting to the agency has remained entirely voluntary. Kennedy’s directive, issued March 10, instructed the acting FDA commissioner to explore rulemaking that would revise the GRAS final rule and eliminate what his office called the self-affirmed pathway.
The new proposal stops short of the full overhaul advocates wanted
Monday’s rule would require companies to submit information on additives, including dyes, preservatives, sweeteners and emulsifiers. It would not force existing GRAS ingredients off shelves while they are under review. The proposal also stops short of establishing a complete premarket approval pathway.
Once the FDA receives a notification, the agency will review it within 45 days to confirm that it meets legal requirements. It will then conduct a more substantive review within 180 days. During that process, the FDA can request additional data or reject the safety determination outright.
Packaged goods already on shelves face no immediate disruption, a detail the food industry had been lobbying for.
Industry accepts the framework while warning about paperwork
Food manufacturers have resisted the framing of GRAS as a dangerous gap, arguing it is a legitimate pathway that Congress created and the FDA has always overseen.
Laura Rich, vice president for regulatory affairs at the Consumer Brands Association, wrote in May that her coalition supports establishing a mandatory notification process for all new substances seeking GRAS status.
Industry groups have simultaneously pressed the agency to staff up, warning that a flood of new filings could create a bottleneck that slows product launches across the sector.
Public health advocates call it overdue but incomplete
Consumer groups have largely welcomed the shift while noting its limits. Scott Faber, senior vice president at the nonprofit Environmental Working Group, told The Washington Post that the reform represents the lowest-hanging fruit available to regulators.
The characterization reflects a broader frustration among advocates who wanted a full premarket approval system rather than a notification requirement, since companies can still self-certify safety, just with the FDA now watching the process unfold in real time.
The move fits a wider pattern in Kennedy’s food agenda
The GRAS proposal follows Kennedy’s earlier push to eliminate synthetic dyes from the food supply. That effort included the FDA’s formal ban on Red Dye No. 3. It also dovetails with his broader Make America Healthy Again platform targeting ultra-processed foods.
Officials framed Monday’s announcement as delivering on that promise without triggering the supply-chain shock a full ban on self-certification might have caused. Any lasting change still requires the agency to complete formal rulemaking, including a public comment period, meaning the practical effect on grocery shelves will not be visible for months at minimum.
What happens next depends on how many companies actually report
The rule’s success hinges less on its legal text than on compliance rates once notification becomes mandatory rather than optional.
Health policy watchers note that voluntary reporting under the old system captured only a fraction of new ingredients entering the market, leaving regulators with an incomplete picture for decades.
Whether mandatory disclosure closes that gap will depend on how the FDA handles the added workload. The rule could improve transparency for consumers, but it could also add paperwork to an already stretched agency. Much will depend on whether the FDA can keep up with the new review queue.
